Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...
It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...
Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...
One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...
Well, a global provider of genomic library and multiplexing workflow solutions, today announced the launch of AgriPreptm Library Prep Kit, the newest addition to its next-generation TnXtm transposase ...
Opinion
7hOpinion
FEDCON Corroborates Treasury Department’s Concerns with their own Independent Research
FEDCON is corroborating recent warnings from the U.S. Department of the Treasury regarding the systemic misuse of ...
Biotechnology instruments market size was valued at USD 92.12 billion in 2025 and is projected to hit the market valuation of USD 141.70 billion by 2035 at a CAGR of 4.4% during the forecast period ...
News-Medical.Net on MSN
Nuclera eProtein Discovery System installed at leading universities in Taiwan
Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through ...
Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback